Literature DB >> 24649126

Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia.

Izumi Inoue1, Jun Kato1, Noriko Yoshimura2, Yoshimasa Maeda1, Kosaku Moribata1, Naoki Shingaki1, Hisanobu Deguchi1, Shotaro Enomoto1, Takao Maekita1, Kazuki Ueda1, Mikitaka Iguchi1, Hideyuki Tamai1, Mitsuhiro Fujishiro3, Nobutake Yamamichi3, Tatsuya Takeshita4, Masao Ichinose1.   

Abstract

In a previous population-based case-control study, we demonstrated an elevated risk of colorectal neoplasia with Helicobacter pylori (H. pylori) infection. The present study investigated the effects of H. pylori-associated chronic gastritis on the development of colorectal neoplasia by analyzing the recurrence of colorectal neoplasia subsequent to endoscopic resection. Ninety-nine patients who had undergone endoscopic resection of colorectal neoplasia were monitored under colonoscopy, and the recurrence of colorectal neoplasia was prospectively investigated. The stage of H. pylori-associated chronic gastritis in each subject was evaluated using a combination of two serum tests: H. pylori antibody and pepsinogen. In the present cohort, colorectal neoplasia recurred at a rate of 15,296/100,000 person-years during the study period. After adjusting for the confounding factors, chronic atrophic gastritis (CAG) was identified as an independent risk factor [adjusted hazard ratio (HR), 2.72; 95% confidence interval, 1.33-5.57], while H. pylori-infected non-atrophic gastritis was not identified as an independent risk factor for recurrent colorectal neoplasia. Colorectal neoplasia recurred earlier and was significantly more frequent in patients with CAG (22,573/100,000 person-years) compared to patients without CAG (11,089/100,000 person-years; P=0.029, log-rank test). Patients with more extensive CAG showed a higher risk of recurrence. These results demonstrated a significant elevation of the risk of recurrent colorectal neoplasia with the establishment and progression of CAG, indicating the involvement of H. pylori infection in the development of colorectal neoplasia. The two serum tests were useful clinical markers for noninvasively evaluating the risk of each individual for recurrent colorectal neoplasia subsequent to endoscopic resection.

Entities:  

Keywords:  chronic atrophic gastritis; cohort study; colorectal neoplasia; pepsinogen; recurrence

Year:  2012        PMID: 24649126      PMCID: PMC3956255          DOI: 10.3892/mco.2012.22

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  47 in total

1.  Incident rates of colonic neoplasia according to age and gender: implications for surveillance colonoscopy intervals.

Authors:  Gavin C Harewood; Garrett O Lawlor
Journal:  J Clin Gastroenterol       Date:  2005 Nov-Dec       Impact factor: 3.062

Review 2.  Extragastric effects of gastrin gene knock-out mice.

Authors:  Theodore J Koh
Journal:  Pharmacol Toxicol       Date:  2002-12

3.  Helicobacter pylori: seroprevalence and colorectal cancer.

Authors:  Z Fireman; L Trost; Y Kopelman; A Segal; A Sternberg
Journal:  Isr Med Assoc J       Date:  2000-01       Impact factor: 0.892

4.  High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.

Authors:  G Meucci; M Tatarella; M Vecchi; M L Ranzi; E Biguzzi; G Beccari; E Clerici; R de Franchis
Journal:  J Clin Gastroenterol       Date:  1997-12       Impact factor: 3.062

5.  Colorectal screening after polypectomy: a national survey study of primary care physicians.

Authors:  Vikram Boolchand; Gregory Olds; Joseph Singh; Pankaj Singh; Amitabh Chak; Gregory S Cooper
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

6.  Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years.

Authors:  Adeyinka O Laiyemo; Gwen Murphy; Paul S Albert; Leah B Sansbury; Zhuoqiao Wang; Amanda J Cross; Pamela M Marcus; Bette Caan; James R Marshall; Peter Lance; Electra D Paskett; Joel Weissfeld; Martha L Slattery; Randall Burt; Frank Iber; Moshe Shike; J Walter Kikendall; Elaine Lanza; Arthur Schatzkin
Journal:  Ann Intern Med       Date:  2008-03-18       Impact factor: 25.391

7.  Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.

Authors:  G D Ciccotosto; A McLeish; K J Hardy; A Shulkes
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

8.  DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon.

Authors:  Michael A Pereira; Wei Wang; Paula M Kramer; Lianhui Tao
Journal:  Cancer Lett       Date:  2004-08-30       Impact factor: 8.679

Review 9.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

10.  Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship?

Authors:  Mary Jones; Peter Helliwell; Colin Pritchard; Joseph Tharakan; Joseph Mathew
Journal:  World J Surg Oncol       Date:  2007-05-12       Impact factor: 2.754

View more
  4 in total

Review 1.  Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.

Authors:  Izumi Inoue; Jun Kato; Hideyuki Tamai; Mikitaka Iguchi; Takao Maekita; Noriko Yoshimura; Masao Ichinose
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 2.  Helicobacter pylori and colorectal neoplasia: Is there a causal link?

Authors:  Vasilios Papastergiou; Stylianos Karatapanis; Sotirios D Georgopoulos
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

3.  Analysis of 234 cases of colorectal polyps treated by endoscopic mucosal resection.

Authors:  Lu Yu; Na Li; Xiao Mei Zhang; Tao Wang; Wei Chen
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

4.  Efficacy and safety of Zuojin Pill for chronic gastritis: Protocol for a systematic review of randomized controlled trials.

Authors:  Jianglong Shi; Liyun Liu; Jian Li; Xiaoju Ma; Hairong Qiu; Tao Shen
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.